101 DEGREES FAHRENHEIT,HODGKIN'S LYMPHOMA,HUMORAL HYPERCALCEMIA OF MALIGNANCY,HYDROA VACCINIFORME,HYPERCALCEMIA,HYPERCALCEMIA ASSOCIATED WITH METASTATIC BREAST CARCINOMA,HYPERCALCEMIA ASSOCIATED WITH NEOPLASM,HYPERCALCEMIA ASSOCIATED WITH SARCOIDOSIS,HYPERCOAGULABILITY STATES,HYPERKALEMIA,HYPERKALEMIC FAMILIAL PERIODIC PARALYSIS,HYPERPARATHYROID BONE DISEASE,HYPERSENSITIVITY ANGIITIS,HYPERTENSIVE RETINOPATHY,HYPERTHYROIDISM,HYPERURICEMIA,HYPOALBUMINEMIA,HYPOGAMMAGLOBULINEMIA,HYPOGLYCEMIC DISORDER,HYPONATREMIA,HYPOPLASTIC ANEMIA,HYPOXIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA,IMMUNOCOMPROMISED PATIENTS,IMMUNOSUPPRESSION,INACTIVE TUBERCULOSIS,INCOMPLETE TESTICULAR DEVELOPMENT,INCREASED CARDIOVASCULAR EVENT RISK,INCREASED CEREBROSPINAL FLUID PRESSURE,INCREASED CREATINE PHOSPHOKINASE,INCREASED GROWTH OF NEVI,INCREASED RISK OF BLEEDING,INFANTILE SPASMS,INFECTED ATOPIC DERMATITIS,INFECTION,INFLAMMATORY BOWEL DISEASE,INTERSTITIAL LUNG DISEASE,INTRACRANIAL HYPERTENSION,INTRACRANIAL LESION,INTRINSIC ASTHMA,IRITIS,KERATITIS,KERATOCONJUNCTIVITIS SICCA,KNEE INFLAMMATION,KRUKENBERG SPINDLE,KYPHOSCOLIOSIS WITH RESPIRATORY COMPROMISE,LARGE OPEN WOUND,LEBER'S HEREDITARY OPTIC ATROPHY,LEUKEMIA,LOIASIS,LOWER RESPIRATORY INFECTIONS,LOWER SEIZURE THRESHOLD,LUNG TRANSPLANTATION,LUPUS-LIKE SYNDROME,LYMPHADENOPATHY,LYMPHOID LEUKEMIA,MACULAR RETINAL EDEMA,MACULOPATHY,MALABSORPTION STATES,MALE HYPOGONADISM,MALIGNANCY,MALIGNANT BONE DISEASE,MALIGNANT BRAIN NEOPLASM,MALIGNANT HYPERTHERMIA,MALIGNANT LYMPHOMA,MALIGNANT MELANOMA,MALIGNANT NEOPLASM OF BONE MARROW,MALIGNANT NEOPLASM OF SKIN,MALIGNANT NEOPLASM OF URINARY SYSTEM,MENINGITIS,METABOLIC BONE DISEASE,MILIARY TUBERCULOSIS,MONOCLONAL GAMMOPATHY,MULTIPLE MYELOMA,MULTIPLE SCLEROSIS,MUSCLE SPASM,MUSCLE WEAKNESS,MUSCULAR DYSTROPHY,MYASTHENIA GRAVIS,MYCOBACTERIOSIS,MYCOSIS FUNGOIDES,MYELODYSPLASTIC SYNDROME,MYOCARDITIS,MYOPATHY,MYOPATHY WITH CK ELEVATION,MYOSITIS,MYOTONIA CONGENITA - AUTOSOMAL DOMINANT FORM,NARROW ANGLE GLAUCOMA,NASAL CONGESTION,NASAL POLYP,NAUSEA,NAUSEA AND VOMITING,NECROTIZING ENTEROCOLITIS,NEOPLASM,NEPHROTIC SYNDROME,NETHERTON'S SYNDROME,NEUROMUSCULAR BLOCKADE,NEUROMUSCULAR DISEASE,NEUROMUSCULAR TRANSMISSION DEFICIENCY,NEUROPATHY,NIGHT BLINDNESS,NON-HODGKIN'S LYMPHOMA,NUTRITIONAL DISORDER,OBSTRUCTIVE PULMONARY DISEASE,OCCLUSIVE VASCULAR DISEASE,OCULAR BLEEDING,OCULAR CYSTICERCOSIS,OCULAR DISORDERS,OCULAR HERPES SIMPLEX,OCULAR HYPERTENSION,OCULAR INFECTION,OCULAR INFLAMMATION,OCULAR INJURY,OCULAR IRRITATION,OCULAR REDNESS,OLIGURIA,OPEN ANGLE GLAUCOMA,OPTIC NEURITIS,OPTIC NEUROPATHY,ORGAN TRANSPLANT WITH IMMUNOSUPPRESSIVE THERAPY,ORGANIC CARDIAC DISEASE,OSTEITIS FIBROSA CYSTICA,OSTEOLYTIC NEOPLASM,OSTEOMALACIA,OSTEOMYELITIS,OSTEOPENIA,OSTEOPOROSIS,OSTEOSARCOMA OF BONE,OTITIS EXTERNA ECZEMA,PAGET'S DISEASE OF BONE,PALMAR-PLANTAR ERYTHRODYSESTHESIA,PAPILLEDEMA,PARALYSIS,PARASITIC INFECTION,PATHOLOGICAL FRACTURE,PEMPHIGUS,PERFORATION OF CORNEA,PERICARDIAL EFFUSION,PERICARDITIS,PERIOPERATIVE CARE,PERIPHERAL MOTOR NEUROPATHY,PERIPHERAL NEUROPATHY,PERIPHERAL VASCULAR DISEASE,PERSISTENT VOMITING,PHLEBITIS,PIGMENTARY RETINOPATHY,PLAQUE PSORIASIS,PNEUMONIA,PORPHYRIA CUTANEA TARDA,PRE-MALIGNANT SKIN LESION,PREDISPOSITION TO GI HEMORRHAGE,PREDISPOSITION TO THROMBOSIS,PREMATURE EPIPHYSEAL CLOSURE,PRIMARY ADRENOCORTICAL INSUFFICIENCY,PRIMARY CLOSED ANGLE GLAUCOMA,PROCTITIS,PROLONGED-SEVERE NAUSEA AND VOMITING,PROSTATIC CARCINOMA,PROTEINURIA,PRURITUS OF SKIN,PSORIASIS,PULMONARY DISEASE,PULMONARY TUBERCULOSIS,PUPILLARY BLOCK GLAUCOMA,PURPURA,PUSTULAR PSORIASIS,RADIATION THERAPY,RAW SKIN,REDUCED VISUAL ACUITY,REFRACTORY LYME ARTHRITIS,RENAL DISEASE,RENAL DISEASE WITH MILD TO MODERATE RENAL FUNCTION IMPAIRMENT,RENAL FAILURE,RENAL OSTEODYSTROPHY,RENAL TRANSPLANT,REPRODUCTIVE SYSTEM DISORDER,RESPIRATORY DISTRESS SYNDROME IN THE NEWBORN,RETINAL DETACHMENT,RETINAL DISORDER,RETINAL HEMORRHAGE,RETINAL THROMBOSIS,REYE'S SYNDROME,RHABDOMYOLYSIS,RHEUMATOID ARTHRITIS,RICKETS,SARCOIDOSIS,SCLERODERMA,SCOLIOSIS,SECONDARY GLAUCOMA,SECONDARY MALIGNANT NEOPLASM OF BONE MARROW,SECONDARY MALIGNANT NEOPLASM OF LYMPH NODES,SEIZURE DISORDER,SEPTIC THROMBOPHLEBITIS,SEVERE ADRENAL INSUFFICIENCY,SEVERE ALLERGIC RHINITIS,SEVERE AND PROGRESSING PARALYSIS,SEVERE ANEMIA,SEVERE BONE MARROW DEPRESSION,SEVERE BURNS,SEVERE CARDIAC DISEASE,SEVERE CARDIOVASCULAR DISEASE,SEVERE COAGULATION DEFECTS,SEVERE CROHN'S DISEASE,SEVERE DIARRHEA,SEVERE HYPOXEMIA,SEVERE INFECTION,SEVERE MYOPIA,SEVERE PRURITUS,SEVERE RENAL DISEASE,SEVERE THROMBOCYTOPENIA,SEVERE ULCERATIVE COLITIS,SEVERE VOMITING,SHALLOW ANTERIOR CHAMBER OF EYE,SHOULDER TENDONITIS,SIGNIFICANT BLEEDING,SKELETAL HYPEROSTOSIS,SKIN AND SKIN STRUCTURE INFECTION,SKIN AND SKIN STRUCTURE NEOPLASM,SKIN ATROPHY,SKIN INFLAMMATION,SKIN IRRITATION,SKIN PHOTOSENSITIVITY,SKIN RASH,SKIN STRIAE,SKIN ULCER,SLIPPED CAPITAL EPIPHYSES,SPASTIC PARALYSIS IN CHILDREN,SPINAL STENOSIS,SPONDYLOLISTHESIS,STATUS ASTHMATICUS,STEATORRHEA,STEVENS-JOHNSON SYNDROME,SUBACUTE INFECTIVE ENDOCARDITIS,SUNBURN,SUPERFICIAL SKIN ULCER,SURGICAL OR OTHER PROCEDURE,SURGICAL WOUND DEHISCENCE,SYNECHIAE OF IRIS,SYSTEMIC INFECTION,SYSTEMIC LUPUS ERYTHEMATOSUS,TARDIVE DYSKINESIA,TEAR FILM INSUFFICIENCY,TELANGIECTASIA,TEMPOROMANDIBULAR JOINT DISORDER,TENDON RUPTURE,TENDONITIS,THROMBOCYTOPENIC DISORDER,THROMBOPHLEBITIS,THROMBOPHLEBITIS MIGRANS,THROMBOSIS IN HEPARIN INDUCED THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA,THYROIDITIS,TOBACCO AMBLYOPIA,TOXIC AMBLYOPIA,TOXIC EPIDERMAL NECROLYSIS,TRANSPLANTATION PROCEDURE,TUBERCULOSIS MENINGITIS,TUBERCULOSIS OF SKIN,TUBERCULOSIS OF THE EAR,TUBERCULOSIS OF THE EYE,ULCERATION OF COLON,ULCERATION OF INTESTINE,ULCERATIVE COLITIS,ULCERATIVE PROCTITIS,UNCONTROLLED BACTERIAL INFECTIONS,UNCONTROLLED COAGULATION DEFECTS,UNCONTROLLED EPILEPSY,UNTREATED BACTERIAL INFECTION,URTICARIA,UVEITIS,VACCINIA VIRUS KERATITIS,VASCULITIS,VERRUCA VULGARIS,VERTEBRAL METASTASES,VIRAL INFECTION,VIRAL INFECTION IN THE EAR,VIRAL OCULAR INFECTION,VIRAL SKIN INFECTION,VISION LOSS,VISUAL CHANGES,VISUAL FIELD DEFECT,VITILIGO,VITREITIS,VITREOUS HEMORRHAGE,VOMITING,WHEEZING,XERODERMA PIGMENTOSUM'/>
Dexamethasone Sodium Phosphate
DEXAMETHASONE SODIUM PHOSPHATE (dexamethasone sodium phosphate/pf)
Drug overview for DEXAMETHASONE SODIUM PHOSPHATE (dexamethasone sodium phosphate/pf):
Generic name: DEXAMETHASONE SODIUM PHOSPHATE/PF
Drug class:
Therapeutic class:
No enhanced Introduction information available for this drug.
No enhanced Uses information available for this drug.
The following indications for DEXAMETHASONE SODIUM PHOSPHATE (dexamethasone sodium phosphate/pf) have been approved by the FDA:
Indications:
None.
Professional Synonyms:
None.
The following dosing information is available for DEXAMETHASONE SODIUM PHOSPHATE (dexamethasone sodium phosphate/pf):
No enhanced Dosing information available for this drug.
No enhanced Administration information available for this drug.
No dosing information available.
No generic dosing information available.
The following drug interaction information is available for DEXAMETHASONE SODIUM PHOSPHATE (dexamethasone sodium phosphate/pf):
There are 0 contraindications.
There are 0 severe interactions.
There are 0 moderate interactions.
The following contraindication information is available for DEXAMETHASONE SODIUM PHOSPHATE (dexamethasone sodium phosphate/pf):
Drug contraindication overview.
No enhanced Contraindications information available for this drug.
There are 0 contraindications.
There are 0 severe contraindications.
There are 0 moderate contraindications.
The following adverse reaction information is available for DEXAMETHASONE SODIUM PHOSPHATE (dexamethasone sodium phosphate/pf):
Adverse reaction overview.
No enhanced Common Adverse Effects information available for this drug.
There are 0 severe adverse reactions.
There are 0 less severe adverse reactions.
The following precautions are available for DEXAMETHASONE SODIUM PHOSPHATE (dexamethasone sodium phosphate/pf):
No enhanced Pediatric Use information available for this drug.
Contraindicated
Severe Precaution
Management or Monitoring Precaution
No enhanced Pregnancy information available for this drug.
No enhanced Lactation information available for this drug.
No enhanced Geriatric Use information available for this drug.
The following prioritized warning is available for DEXAMETHASONE SODIUM PHOSPHATE (dexamethasone sodium phosphate/pf):
No warning message for this drug.
The following icd codes are available for DEXAMETHASONE SODIUM PHOSPHATE (dexamethasone sodium phosphate/pf)'s list of indications:
No ICD codes found for this drug.
Formulary Reference Tool
Please wait while the formulary information is being retrieved.